08 sep 25   ondine biomedical - notification of major holdings - hinsight ondine biomedical, inc. | obi | 15.2 0 0.0% | mkt cap: 79.1m    rns number : 2981y ondine biomedical inc. 08 september 2025     tr-1: standard form for notification of major holdings   notification of major holdings (to be sent to the relevant issuer and to the fca in microsoft word format if possible) i  1a. identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: ondine biomedical inc. 1b. please indicate if the issuer is a non-uk issuer  (please mark with an "x" if appropriate) non-uk issuer x 2. reason for the notification (please mark the appropriate box or boxes with an "x") an acquisition or disposal of voting rights  an acquisition or disposal of financial instruments  an event changing the breakdown of voting rights x other (please specify) iii:  3. details of person subject to the notification obligation iv name hinsight-nx, llc city and country of registered office (if applicable) nashville, united states 4. full name of shareholder(s) (if different from 3.) v name  city and country of registered office (if applicable)  5. date on which the threshold was crossed or reached vi: 03/09/2025 6. date on which issuer notified (dd/mm/yyyy): 04/09/2025 7. total positions of person(s) subject to the notification obligation  % of voting rights attached to shares (total of 8. a) % of voting rights through financial instruments (total of 8.b 1 + 8.b 2) total of both in % (8.a + 8.b) total number of voting rights held in issuer (8.a + 8.b) vii resulting situation on the date on which threshold was crossed or reached   8.154967%   0.000000%   8.154967% 42,272,654 position of previous notification (if applicable)       8. notified details of the resulting situation on the date on which the threshold was crossed or reached viii a: voting rights attached to shares class/type of shares isin code (if possible) number of voting rights ix % of voting rights direct (dtr5.1) indirect  (dtr5.2.1) direct (dtr5.1) indirect (dtr5.2.1) ca68234m2058 42,272,654  8.154967%            subtotal 8. a 42,272,654 8.154967%     b 1: financial instruments according to dtr5.3.1r (1) (a) type of financial instrument expiration date x exercise/ conversion period xi number of voting rights that may be acquired if the instrument is exercised/converted. % of voting rights                  subtotal 8. b 1       b 2: financial instruments with similar economic effect according to dtr5.3.1r (1) (b) type of financial instrument expiration date x exercise/ conversion period xi physical or cash settlement xii number of voting rights % of voting rights                       subtotal 8.b.2         9. information in relation to the person subject to the notification obligation (please mark the applicable box with an "x") person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii x full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv  name xv % of voting rights if it equals or is higher than the notifiable threshold % of voting rights through financial instruments if it equals or is higher than the notifiable threshold total of both if it equals or is higher than the notifiable threshold hinsight-nx, llc 8.154967%  8.154967%                   10. in case of proxy voting, please identify: name of the proxy holder  the number and % of voting rights held  the date until which the voting rights will be held   11. additional information xvi    place of completion london, uk date of completion 03/09/2025           this information is provided by rns, the news service of the london stock exchange. rns is approved by the financial conduct authority to act as a primary information provider in the united kingdom. terms and conditions relating to the use and distribution of this information may apply. for further information, please contact rns@lseg.com or visit www.rns.com.  rns may use your ip address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. for further information about how rns and the london stock exchange use the personal data you provide us, please see our privacy policy.   end   holupupcbupagra return to news summary

Label: Gesunken